F
Financials.page
Company Fundamentals
Workspace
OverviewhomeCompaniesdirectoryAPI & MCPdevelopers
Company financial data, refreshed daily. Not investment advice.
Financials.page — company financial data, refreshed daily. Not investment advice. Legal & terms
Annual figures as reported in 10-K / 20-F / 40-F filings.
HYEX · CIK 0001630176

Healthy Extracts Inc.

Annual figures as reported, FY2014–FY2025. Ratios and growth rates derived on-page.

HYEX logo
Medicinal Chemicals & Botanical Products
Company profile
OTC · HYEXHQ Henderson, NVIncorporated in NVFiscal year ends Dec 31Non-accelerated filer Smaller reporting company
Revenue
$4.5M
▲ +44.9% vs FY2024
Net income
−$881K
▼ −4.8% vs FY2024
Free cash flow
−$416K
▼ −4.3% vs FY2022
Total assets
$27.8M
▲ +1070.1% vs FY2024

Revenue

Annual, as reported

02M4M’15’17’19’21’23’25$4.5M

Net income

Losses shown in terracotta

−2M0’15’17’19’21’23’25−$881K

Recent quarters

momentum · last 12 quarters
Revenue — Mar ’26 quarter
$1.6M
▲ +73.0% vs Mar ’25
Net income — Mar ’26 quarter
−$201K
▲ +49.7% vs Mar ’25
Revenue — trailing 12 months
$5.2M
▲ +54.7% vs Mar ’25

Quarterly revenue

Discrete quarters; Q4 derived from the annual figure

0500K1M1.5MJun ’23Dec ’23Jun ’24Dec ’24Jun ’25Dec ’25Mar ’26$1.6M

Quarterly net income

Losses shown in terracotta

−1M−500K0Jun ’23Dec ’23Jun ’24Dec ’24Jun ’25Dec ’25Mar ’26−$201K
QuarterRevenueRev. YoYGross marginNet incomeNet marginDiluted EPS
Mar ’26$1.6M73.0%61.4%−$201K−12.5%—
Dec ’25$1.7M119.7%56.5%−$154K−9.1%—
Sep ’25$918K23.2%48.7%−$395K−43.1%—
Jun ’25$969K6.6%61.2%$67K6.9%—
Mar ’25$931K35.2%45.6%−$399K−42.8%—
Dec ’24$771K15.3%53.7%−$447K−58.0%—
Sep ’24$745K21.4%80.9%$354K47.6%—
Jun ’24$908K54.4%53.5%$114K12.5%—

Profitability & returns

quality of earnings

Margins

Share of revenue kept at each line

-40000%-20000%0%’15’17’19’21’23’25
Gross marginNet margin

Returns on capital

Net income vs year-end equity and assets

-3000%-2000%-1000%0%’15’17’19’21’23’25
Return on equityReturn on assets

Cash flow

cash generation

Free cash flow

Operating cash flow less capital expenditure

−1.5M−1M−500K0’19’21’22’23−$416K

Operating cash flow

Net cash from operations

−1M0’15’17’19’21’23’25$166K

Balance sheet

financial position

Stockholders’ equity

At fiscal year end

010M20M’14’16’18’20’22’24’25$24.0M

Growth rates

compounding, annualized
Revenue CAGR
+26.1%
3y
+28.3%
5y
+44.3%
10y

Key ratios

derived per fiscal year
Fiscal yearGross marginNet marginFCF marginROEROACurrent ratio
FY202553.7%−19.5%—−3.7%−3.2%0.79×
FY202461.4%−27.0%—−204.9%−35.4%1.24×
FY202365.2%−99.5%−16.7%−259.1%−93.8%1.13×
FY202260.9%−43.7%−17.7%−52.5%−35.3%2.26×
FY202141.5%−118.5%−53.8%−80.4%−65.6%4.14×
FY2020−44.5%−198.3%—−90.3%−82.7%9.52×
FY201929.9%84.6%−234.3%—18.3%0.75×
FY201857.4%−4959.7%——−3882.0%0.00×
FY201737.4%−46838.6%——−317.3%0.06×
FY201683.5%−2071.2%——−2306.0%0.06×
FY201559.6%−632.5%—−562.3%−471.2%5.98×
FY2014——————

Annual figures

as reported
Fiscal yearRevenueGross profitOp. incomeNet incomeDiluted EPSOp. cash flowCapexTotal assetsLiabilitiesEquityCashLT debt
FY2025$4.5M$2.4M—−$881K—$166K—$27.8M$3.8M$24.0M$147K—
FY2024$3.1M$1.9M—−$841K—$282K—$2.4M$2.0M$410K$112K—
FY2023$2.5M$1.6M—−$2.5M—−$416K$0$2.6M$1.7M$955K$19K—
FY2022$2.3M$1.4M—−$983K—−$391K$8K$2.8M$910K$1.9M$66K—
FY2021$1.7M$695K—−$2.0M—−$901K$0$3.0M$559K$2.5M$222K—
FY2020$1.3M−$578K—−$2.6M—−$1.9M—$3.1M$262K$2.9M$59K—
FY2019$748K$224K—$633K—−$1.7M$23K$3.4M$4.3M−$866K——
FY2018$67K$39K—−$3.3M—−$329K—$86K$3.6M−$3.6M——
FY2017$8K$3K—−$3.6M—−$672K—$1.1M$2.3M−$1.2M——
FY2016$163K$136K—−$3.4M—−$537K—$146K$2.5M−$2.4M——
FY2015$116K$69K—−$731K—−$498K—$155K$25K$130K——
FY2014———————$733$0$733——

Latest filings

the most recent regulatory filings
8-KHEALTHY EXTRACTS INC. - FORM 8-K SEC FILING2026-05-18 ↗10-QHEALTHY EXTRACTS INC. - FORM 10-Q SEC FILING2026-05-14 ↗10-KHEALTHY EXTRACTS INC. - FORM 10-K SEC FILING2026-04-09 ↗NT 10-KHEALTHY EXTRACTS INC. 12B-252026-04-01 ↗10-QHEALTHY EXTRACTS INC. - FORM 10-Q SEC FILING2025-11-14 ↗8-KHEALTHY EXTRACTS INC. - FORM 8-K SEC FILING2025-10-02 ↗8-KHEALTHY EXTRACTS INC. - FORM 8-K SEC FILING2025-09-23 ↗SCHEDULE 13DSEC filing2025-08-22 ↗4PRIMARY DOCUMENT2025-08-22 ↗3PRIMARY DOCUMENT2025-08-22 ↗

Company logos by Elbstream and unavatar.

All third-party trademarks, service marks, logos, and brand names used on this site are the property of their respective owners. The use of these logos is for identification and illustrative purposes only and does not imply any affiliation, sponsorship, or endorsement by the respective owners.